Abstract
Alzheimer’s disease is characterized by the accumulation of Aβ plaques and tau protein tangles, with TRIM11 playing a crucial role in tau regulation [1]. However, TRIM11’s degradation in Alzheimer’s remains unclear. This study investigates whether lysosomes, responsible for cellular degradation, are involved in TRIM11 degradation [2]. Lysosome inhibitors were applied, and TRIM11 levels were examined. Immunostaining for TRIM11 and lysosome inhibitors was conducted to assess co-localization, indicating potential interaction. The findings suggest a connection between TRIM11 and lysosomes in Alzheimer’s pathology, warranting further research for potential therapeutic implications [3].
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call